
PHOENIX — Stepping down asthma medicines can be done safely and at a
lower cost for patients, says a new Mayo Clinic study published recently
in The Journal of Allergy and Clinical Immunology.
It is common
for patients and doctors to test if taking less daily asthma medicine is
safe — primarily because of the high cost of asthma medicine. However,
deciding when to reduce daily asthma medicines can be challenging, and
it would be helpful to understand the risks involved.
The study,
led by Dr. Matthew Rank, an allergy and immunology specialist at Mayo
Clinic in Arizona, analyzed asthma outcomes after patients stepped down
their daily asthma medicines. The team studied more than 4,000 patients
(adults and children) who were taking daily asthma medicines and focused
their analysis on two groups: Patients who had stable asthma for at
least one year who stayed on their same daily asthma medicine and
patients who had stable asthma for at least one year who stepped down
their daily asthma medicine.
Stepping down asthma medicines in
patients who have had stable asthma for at least one year appears to be
as safe as continuing the same level of medicines, the study found. Only
11 percent of patients had problems with their asthma in the four to
five months after stepping down their asthma medicines.
"Trying to
reduce the daily asthma medicine speaks to the principle of using the
least amount of medicine to control symptoms and prevent attacks," Rank
said.
READ MORE